Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals

Radiolabeling and comparative studies of [18F]DPA-714, [18F]PBR111 AND [18F]FEDAA1106, potent TSPO 18kDa PET-imaging candidates

Annelaure Damont, Nadja Van Camp, Bertrand Kuhnast, Raphael Boisgard, Fabien Chauveau, Katrin Probst, Andrew Katsifis, Mickael Kassiou, Bertrand Tavitian and Frederic Dolle
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1962;
Annelaure Damont
1CEA, I2BM Service Hospitalier Frederic Joliot, Orsay, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadja Van Camp
1CEA, I2BM Service Hospitalier Frederic Joliot, Orsay, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bertrand Kuhnast
1CEA, I2BM Service Hospitalier Frederic Joliot, Orsay, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raphael Boisgard
1CEA, I2BM Service Hospitalier Frederic Joliot, Orsay, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabien Chauveau
1CEA, I2BM Service Hospitalier Frederic Joliot, Orsay, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katrin Probst
2University of Edinburgh, Edinburgh, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Katsifis
3ANSTO, Lucas Heights, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mickael Kassiou
4University of Sydney, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bertrand Tavitian
1CEA, I2BM Service Hospitalier Frederic Joliot, Orsay, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederic Dolle
1CEA, I2BM Service Hospitalier Frederic Joliot, Orsay, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 50 no. supplement 2 1962

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
© 2009 by Society of Nuclear Medicine

Author Information

  1. Annelaure Damont1,
  2. Nadja Van Camp1,
  3. Bertrand Kuhnast1,
  4. Raphael Boisgard1,
  5. Fabien Chauveau1,
  6. Katrin Probst2,
  7. Andrew Katsifis3,
  8. Mickael Kassiou4,
  9. Bertrand Tavitian1 and
  10. Frederic Dolle1
  1. 1CEA, I2BM Service Hospitalier Frederic Joliot, Orsay, France
  2. 2University of Edinburgh, Edinburgh, United Kingdom
  3. 3ANSTO, Lucas Heights, Australia
  4. 4University of Sydney, Sydney, Australia

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: April 2015 to December 2022

AbstractFullPdf
Apr 2015100
May 2015100
Jun 2015100
Jul 2015100
Sep 2015500
Nov 2015100
Feb 2016100
Mar 2016300
Jun 2016200
Jul 2016100
Aug 2016300
Oct 2016300
Nov 2016600
Jan 2017200
Feb 2017500
Mar 2017200
Apr 2017100
May 2017200
Jun 2017200
Aug 2017200
Sep 2017500
Oct 2017300
Nov 2017200
Dec 2017200
Jan 2018100
Feb 2018100
Mar 2018100
Apr 2018100
Jun 2018100
Jul 2018100
Aug 2018100
Sep 2018500
Nov 2018500
Dec 2018200
Feb 2019100
Apr 2019200
May 2019300
Jun 2019200
Jul 2019200
Aug 2019800
Oct 2019300
Nov 2019300
Dec 2019500
Jan 2020100
Feb 2020600
Mar 20201500
Apr 2020800
Jul 2020200
Aug 20209200
Sep 202011900
Oct 20201400
Nov 20202200
Dec 2020700
Jan 2021400
Feb 20211600
Mar 20211700
Apr 20211200
May 2021600
Jun 2021400
Jul 20211900
Aug 20213200
Sep 20211100
Oct 20211300
Nov 20219200
Dec 20215100
Jan 20227500
Feb 20222400
Mar 20221900
Apr 20221600
May 20223700
Jun 2022900
Aug 2022600
Sep 20221700
Oct 2022100
Nov 2022100
Dec 2022200
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 50, Issue supplement 2
May 2009
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiolabeling and comparative studies of [18F]DPA-714, [18F]PBR111 AND [18F]FEDAA1106, potent TSPO 18kDa PET-imaging candidates
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiolabeling and comparative studies of [18F]DPA-714, [18F]PBR111 AND [18F]FEDAA1106, potent TSPO 18kDa PET-imaging candidates
Annelaure Damont, Nadja Van Camp, Bertrand Kuhnast, Raphael Boisgard, Fabien Chauveau, Katrin Probst, Andrew Katsifis, Mickael Kassiou, Bertrand Tavitian, Frederic Dolle
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1962;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiolabeling and comparative studies of [18F]DPA-714, [18F]PBR111 AND [18F]FEDAA1106, potent TSPO 18kDa PET-imaging candidates
Annelaure Damont, Nadja Van Camp, Bertrand Kuhnast, Raphael Boisgard, Fabien Chauveau, Katrin Probst, Andrew Katsifis, Mickael Kassiou, Bertrand Tavitian, Frederic Dolle
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1962;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals

  • Radiolabeling optimization of a cysteine-dextran lymph node seeking molecule using 99mTc-tricarbonyl core
  • 111In-DTPA-exendin-4 SPECT/CT scans localize hardly detectable insulinomas
  • Synthesis and β-amyloid binding properties of rhenium 2-arylbenzothiazoles
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals

New Radiopharmaceuticals-Novel Probe Development Posters

  • Evaluation of 123I-ICdR as a novel SPECT proliferation probe in a sarcoma-bearing mouse model
  • Development and initial evaluation of novel fluorine-18 labeled nanocarrier "Lactosome" as a tumor imaging probe for PET
  • Iodine-131 D-amino acid peptide, a novel bi-functional chelating agent for improving therapeutic application of Rituximab
Show more New Radiopharmaceuticals-Novel Probe Development Posters

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire